Samjin in strategic alliance with ImQuest over anti-viral drug development.

Published: 2006-02-01 06:59:00

Updated: 2006-02-01 06:59:00

Samjin announced to make a strategic alliance with ImQuest, an American company, for the clinical research of new anti-viral drugs developed by Samjin according to Fox 5 news, a foreign correspondence.

The news said that Samjin developed 3 innovative antiviral new compounds for the treatment o...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK